Click here to get full coverage on Does Alaska Air Group’s (ALK) Rapid Response to FAA Disruptions Reflect Long-Term Operational Resilience? - Yahoo Finance

Does Alaska Air Group’s (ALK) Rapid Response to FAA Disruptions Reflect Long-Term Operational Resilience?  Yahoo Finance

Does Alaska Air Group’s (ALK) Rapid Response to FAA Disruptions Reflect Long-Term Operational Resilience? - Yahoo Finance

Click here to get full coverage on ALK-Abelló delivers 18% global revenue growth, profit up 41% - The Pharma Letter

ALK-Abelló delivers 18% global revenue growth, profit up 41%  The Pharma Letter

ALK-Abelló delivers 18% global revenue growth, profit up 41% - The Pharma Letter

Click here to get full coverage on ALK-abello A/S Earnings Call Highlights Growth and Challenges - TipRanks

ALK-abello A/S Earnings Call Highlights Growth and Challenges  TipRanks

ALK-abello A/S Earnings Call Highlights Growth and Challenges - TipRanks

Click here to get full coverage on ALK invests heavily in children's allergies after strong quarter - medwatch.com

ALK invests heavily in children's allergies after strong quarter  medwatch.com

ALK invests heavily in children's allergies after strong quarter - medwatch.com

Click here to get full coverage on Alaska Airlines (NYSE: ALK) opens $599 Seattle–Rome fares; daily 787-9 service - Stock Titan

Alaska Airlines (NYSE: ALK) opens $599 Seattle–Rome fares; daily 787-9 service  Stock Titan

Alaska Airlines (NYSE: ALK) opens $599 Seattle–Rome fares; daily 787-9 service - Stock Titan

Click here to get full coverage on ALK-Abelló raises 2025 outlook after strong Q3, shares jump 11% - Investing.com

ALK-Abelló raises 2025 outlook after strong Q3, shares jump 11%  Investing.com

ALK-Abelló raises 2025 outlook after strong Q3, shares jump 11% - Investing.com

Click here to get full coverage on Alk-Abello AS (AKBLF) Q3 2025 Earnings Call Highlights: Robust R - GuruFocus

Alk-Abello AS (AKBLF) Q3 2025 Earnings Call Highlights: Robust R  GuruFocus

Alk-Abello AS (AKBLF) Q3 2025 Earnings Call Highlights: Robust R - GuruFocus

Click here to get full coverage on A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers - Nature

A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers  Nature

A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers - Nature

Click here to get full coverage on How FAA Shutdown-Driven Flight Cancellations Could Impact Alaska Air Group (ALK) Investors - simplywall.st

How FAA Shutdown-Driven Flight Cancellations Could Impact Alaska Air Group (ALK) Investors  simplywall.st

How FAA Shutdown-Driven Flight Cancellations Could Impact Alaska Air Group (ALK) Investors - simplywall.st

Click here to get full coverage on Can ALK stock deliver strong annual returns - Market Weekly Review & Daily Stock Trend Watchlist - newser.com

Can ALK stock deliver strong annual returns - Market Weekly Review & Daily Stock Trend Watchlist  newser.com

Can ALK stock deliver strong annual returns - Market Weekly Review & Daily Stock Trend Watchlist - newser.com

Click here to get full coverage on Assessing ALK-Abelló (CPSE:ALK B) Valuation After Sustained Shareholder Returns and Growth Momentum - Yahoo Finance

Assessing ALK-Abelló (CPSE:ALK B) Valuation After Sustained Shareholder Returns and Growth Momentum  Yahoo Finance

Assessing ALK-Abelló (CPSE:ALK B) Valuation After Sustained Shareholder Returns and Growth Momentum - Yahoo Finance

Click here to get full coverage on ALK boosted by robust children’s tablet sales in Q3 - medwatch.com

ALK boosted by robust children’s tablet sales in Q3  medwatch.com

ALK boosted by robust children’s tablet sales in Q3 - medwatch.com

Click here to get full coverage on Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approach - Nature

Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approach  Nature

Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approach - Nature

Click here to get full coverage on Alaska Air Group (ALK): Evaluating Valuation as FAA Order Spurs Flight Cancellations and Ongoing Uncertainty - simplywall.st

Alaska Air Group (ALK): Evaluating Valuation as FAA Order Spurs Flight Cancellations and Ongoing Uncertainty  simplywall.st

Alaska Air Group (ALK): Evaluating Valuation as FAA Order Spurs Flight Cancellations and Ongoing Uncertainty - simplywall.st

Click here to get full coverage on ALK upgrades full-year guidance - medwatch.com

ALK upgrades full-year guidance  medwatch.com

ALK upgrades full-year guidance - medwatch.com

Click here to get full coverage on Evidential deep learning-based ALK-expression screening using H&E-stained histopathological images - Nature

Evidential deep learning-based ALK-expression screening using H&E-stained histopathological images  Nature

Evidential deep learning-based ALK-expression screening using H&E-stained histopathological images - Nature

Click here to get full coverage on Compared to Estimates, Alaska Air (ALK) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Compared to Estimates, Alaska Air (ALK) Q3 Earnings: A Look at Key Metrics  Yahoo Finance

Compared to Estimates, Alaska Air (ALK) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Click here to get full coverage on Preview of ALK financial results: Double-digit growth may be on the way - medwatch.com

Preview of ALK financial results: Double-digit growth may be on the way  medwatch.com

Preview of ALK financial results: Double-digit growth may be on the way - medwatch.com

Click here to get full coverage on Alaska Air Group Inc. (ALK) Posts Record Revenue but Misses Profit Targets - Yahoo Finance

Alaska Air Group Inc. (ALK) Posts Record Revenue but Misses Profit Targets  Yahoo Finance

Alaska Air Group Inc. (ALK) Posts Record Revenue but Misses Profit Targets - Yahoo Finance

Click here to get full coverage on Alaska Air Group (NYSE: ALK) elevates Engel, Zendejas, Ruger, Converse to operations roles - Stock Titan

Alaska Air Group (NYSE: ALK) elevates Engel, Zendejas, Ruger, Converse to operations roles  Stock Titan

Alaska Air Group (NYSE: ALK) elevates Engel, Zendejas, Ruger, Converse to operations roles - Stock Titan

Click here to get full coverage on Alectinib in combination with bevacizumab as first-line treatment in ALK -rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial - Nature

Alectinib in combination with bevacizumab as first-line treatment in ALK -rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial  Nature

Alectinib in combination with bevacizumab as first-line treatment in ALK -rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial - Nature

Click here to get full coverage on Why Airlines May Hold Pricing Power Into 2026 Even After Shutdown Disruptions - Benzinga

Why Airlines May Hold Pricing Power Into 2026 Even After Shutdown Disruptions  Benzinga

Why Airlines May Hold Pricing Power Into 2026 Even After Shutdown Disruptions - Benzinga

Click here to get full coverage on ALK-based dual inhibitors: Focus on recent development for non-small cell lung cancer therapy - ScienceDirect.com

ALK-based dual inhibitors: Focus on recent development for non-small cell lung cancer therapy  ScienceDirect.com

ALK-based dual inhibitors: Focus on recent development for non-small cell lung cancer therapy - ScienceDirect.com

Click here to get full coverage on Is Alaska Air (ALK) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance

Is Alaska Air (ALK) a Buy as Wall Street Analysts Look Optimistic?  Yahoo Finance

Is Alaska Air (ALK) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance

Click here to get full coverage on ALK inhibitors against resistance in non-small cell lung cancer: an 18 year medical arms race - ScienceDirect.com

ALK inhibitors against resistance in non-small cell lung cancer: an 18 year medical arms race  ScienceDirect.com

ALK inhibitors against resistance in non-small cell lung cancer: an 18 year medical arms race - ScienceDirect.com

Click here to get full coverage on ALK in cancer: from function to therapeutic targeting - Nature

ALK in cancer: from function to therapeutic targeting  Nature

ALK in cancer: from function to therapeutic targeting - Nature

Click here to get full coverage on Alaska Air Group, Inc. (ALK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Alaska Air Group, Inc. (ALK) Is a Trending Stock: Facts to Know Before Betting on It  Yahoo Finance

Alaska Air Group, Inc. (ALK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Click here to get full coverage on Alecensa Improves 4-Year Survival in Early ALK-Positive Lung Cancer - Cure Today

Alecensa Improves 4-Year Survival in Early ALK-Positive Lung Cancer  Cure Today

Alecensa Improves 4-Year Survival in Early ALK-Positive Lung Cancer - Cure Today

Click here to get full coverage on Alaska Air Group (ALK): Revisiting Valuation After Recent Share Price Slide - Yahoo Finance

Alaska Air Group (ALK): Revisiting Valuation After Recent Share Price Slide  Yahoo Finance

Alaska Air Group (ALK): Revisiting Valuation After Recent Share Price Slide - Yahoo Finance

Click here to get full coverage on Frontline Alecensa Extends Survival in Advanced ALK-Positive Lung Cancer - Cure Today

Frontline Alecensa Extends Survival in Advanced ALK-Positive Lung Cancer  Cure Today

Frontline Alecensa Extends Survival in Advanced ALK-Positive Lung Cancer - Cure Today

Click here to get full coverage on Bank of America Securities Reiterates Buy Rating on Alaska Air Group (ALK) Stock - Yahoo Finance

Bank of America Securities Reiterates Buy Rating on Alaska Air Group (ALK) Stock  Yahoo Finance

Bank of America Securities Reiterates Buy Rating on Alaska Air Group (ALK) Stock - Yahoo Finance

Click here to get full coverage on Alaska Air Group Inc. (ALK) Stock: Rises Despite Flight Cancellations and FAA Directive Impact - CoinCentral

Alaska Air Group Inc. (ALK) Stock: Rises Despite Flight Cancellations and FAA Directive Impact  CoinCentral

Alaska Air Group Inc. (ALK) Stock: Rises Despite Flight Cancellations and FAA Directive Impact - CoinCentral

Click here to get full coverage on Response to Alectinib in Refractory Breast Cancer With an EML4-ALK Rearrangement - Journal of Hematology Oncology Pharmacy

Response to Alectinib in Refractory Breast Cancer With an EML4-ALK Rearrangement  Journal of Hematology Oncology Pharmacy

Response to Alectinib in Refractory Breast Cancer With an EML4-ALK Rearrangement - Journal of Hematology Oncology Pharmacy

Click here to get full coverage on Alaska Air Group (ALK) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance

Alaska Air Group (ALK) Stock Sinks As Market Gains: What You Should Know  Yahoo Finance

Alaska Air Group (ALK) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance

Click here to get full coverage on Alaska Air (ALK) Up 8.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Alaska Air (ALK) Up 8.1% Since Last Earnings Report: Can It Continue?  Yahoo Finance

Alaska Air (ALK) Up 8.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Click here to get full coverage on Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alaska Air Group, Inc. (ALK) And Encourages Investors to Reach Out - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alaska Air Group, Inc. (ALK) And Encourages Investors to Reach Out  ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alaska Air Group, Inc. (ALK) And Encourages Investors to Reach Out - ACCESS Newswire

Click here to get full coverage on Earnings Preview: Alaska Air Group (ALK) Q3 Earnings Expected to Decline - Yahoo Finance

Earnings Preview: Alaska Air Group (ALK) Q3 Earnings Expected to Decline  Yahoo Finance

Earnings Preview: Alaska Air Group (ALK) Q3 Earnings Expected to Decline - Yahoo Finance

Click here to get full coverage on Advanced test predicts ALK inhibitor success in lung cancer - Drug Target Review

Advanced test predicts ALK inhibitor success in lung cancer  Drug Target Review

Advanced test predicts ALK inhibitor success in lung cancer - Drug Target Review

Click here to get full coverage on Circulating tumor DNA in ALK-positive anaplastic large cell lymphoma: a proof-of-concept study - Nature

Circulating tumor DNA in ALK-positive anaplastic large cell lymphoma: a proof-of-concept study  Nature

Circulating tumor DNA in ALK-positive anaplastic large cell lymphoma: a proof-of-concept study - Nature

Click here to get full coverage on Is Now the Moment to Reassess ALK-Abelló After Shares Jump 24% in 2025? - Yahoo Finance

Is Now the Moment to Reassess ALK-Abelló After Shares Jump 24% in 2025?  Yahoo Finance

Is Now the Moment to Reassess ALK-Abelló After Shares Jump 24% in 2025? - Yahoo Finance

Click here to get full coverage on Crizotinib Not Beneficial in Resected Early ALK+NSCLC - Medscape

Crizotinib Not Beneficial in Resected Early ALK+NSCLC  Medscape

Crizotinib Not Beneficial in Resected Early ALK+NSCLC - Medscape

Click here to get full coverage on Study Investigates Psychologic Burden and Challenges of ALK-Positive NSCLC - Cancer Nursing Today

Study Investigates Psychologic Burden and Challenges of ALK-Positive NSCLC  Cancer Nursing Today

Study Investigates Psychologic Burden and Challenges of ALK-Positive NSCLC - Cancer Nursing Today

Click here to get full coverage on Airline Stock Roundup: ALK's Bearish Q3 View, DAL,UAL in Focus - Yahoo Finance

Airline Stock Roundup: ALK's Bearish Q3 View, DAL,UAL in Focus  Yahoo Finance

Airline Stock Roundup: ALK's Bearish Q3 View, DAL,UAL in Focus - Yahoo Finance

Click here to get full coverage on Exploring First-Line ALK Inhibitors, TKI Sequencing in ALK-Positive NSCLC - CancerNetwork

Exploring First-Line ALK Inhibitors, TKI Sequencing in ALK-Positive NSCLC  CancerNetwork

Exploring First-Line ALK Inhibitors, TKI Sequencing in ALK-Positive NSCLC - CancerNetwork

Click here to get full coverage on Identifying Biomarkers of Therapeutic Resistance with Lorlatinib in Patients with ALK-Positive Advanced NSCLC - Cancer Nursing Today

Identifying Biomarkers of Therapeutic Resistance with Lorlatinib in Patients with ALK-Positive Advanced NSCLC  Cancer Nursing Today

Identifying Biomarkers of Therapeutic Resistance with Lorlatinib in Patients with ALK-Positive Advanced NSCLC - Cancer Nursing Today

Click here to get full coverage on Alaska Airlines (ALK): $282 Million One-Off Loss Tests Margin Recovery Narratives - Yahoo Finance

Alaska Airlines (ALK): $282 Million One-Off Loss Tests Margin Recovery Narratives  Yahoo Finance

Alaska Airlines (ALK): $282 Million One-Off Loss Tests Margin Recovery Narratives - Yahoo Finance

Click here to get full coverage on Alaska Air Group (ALK): Assessing Valuation as Iceland Route Expands Transatlantic Reach and International Strategy - Yahoo Finance

Alaska Air Group (ALK): Assessing Valuation as Iceland Route Expands Transatlantic Reach and International Strategy  Yahoo Finance

Alaska Air Group (ALK): Assessing Valuation as Iceland Route Expands Transatlantic Reach and International Strategy - Yahoo Finance

Click here to get full coverage on ALEX Trial Final Results at ESMO 2025: Alectinib Demonstrates Durable Overall Survival and Long-Term Disease Control in Advanced ALK-Positive NSCLC - Oncodaily

ALEX Trial Final Results at ESMO 2025: Alectinib Demonstrates Durable Overall Survival and Long-Term Disease Control in Advanced ALK-Positive NSCLC  Oncodaily

ALEX Trial Final Results at ESMO 2025: Alectinib Demonstrates Durable Overall Survival and Long-Term Disease Control in Advanced ALK-Positive NSCLC - Oncodaily

Click here to get full coverage on Alaska Air Group (ALK) Advances While Market Declines: Some Information for Investors - Yahoo Finance

Alaska Air Group (ALK) Advances While Market Declines: Some Information for Investors  Yahoo Finance

Alaska Air Group (ALK) Advances While Market Declines: Some Information for Investors - Yahoo Finance

Click here to get full coverage on Objective long/short (ALK) Report (ALK:CA) - news.stocktradersdaily.com

Objective long/short (ALK) Report (ALK:CA)  news.stocktradersdaily.com

Objective long/short (ALK) Report (ALK:CA) - news.stocktradersdaily.com

Click here to get full coverage on Case Report: Metastatic colorectal cancer with ALK–CEP44 fusion and rapid resistance development - Frontiers

Case Report: Metastatic colorectal cancer with ALK–CEP44 fusion and rapid resistance development  Frontiers

Case Report: Metastatic colorectal cancer with ALK–CEP44 fusion and rapid resistance development - Frontiers

Click here to get full coverage on Brokers Suggest Investing in Alaska Air (ALK): Read This Before Placing a Bet - Yahoo Finance

Brokers Suggest Investing in Alaska Air (ALK): Read This Before Placing a Bet  Yahoo Finance

Brokers Suggest Investing in Alaska Air (ALK): Read This Before Placing a Bet - Yahoo Finance

Click here to get full coverage on An Overview and Guide for Patients by ALK-Positive NSCLC Patients and Medical Experts - Oncodaily

An Overview and Guide for Patients by ALK-Positive NSCLC Patients and Medical Experts  Oncodaily

An Overview and Guide for Patients by ALK-Positive NSCLC Patients and Medical Experts - Oncodaily

Click here to get full coverage on ALK and Lung Cancer - American Lung Association

ALK and Lung Cancer  American Lung Association

ALK and Lung Cancer - American Lung Association

Click here to get full coverage on Remarkable tumor response to Iruplinalkib in a 14-year-old girl with ALK-positive advanced metastatic non–small-cell lung cancer: a case report - Frontiers

Remarkable tumor response to Iruplinalkib in a 14-year-old girl with ALK-positive advanced metastatic non–small-cell lung cancer: a case report  Frontiers

Remarkable tumor response to Iruplinalkib in a 14-year-old girl with ALK-positive advanced metastatic non–small-cell lung cancer: a case report - Frontiers

Click here to get full coverage on Study Investigates Tailored Sequencing Strategies to Extend Survival in ALK-Positive Advanced NSCLC - Cancer Nursing Today

Study Investigates Tailored Sequencing Strategies to Extend Survival in ALK-Positive Advanced NSCLC  Cancer Nursing Today

Study Investigates Tailored Sequencing Strategies to Extend Survival in ALK-Positive Advanced NSCLC - Cancer Nursing Today

Click here to get full coverage on Alkane Resources (ASX:ALK): Is the Current Valuation Justified After Recent Share Price Surge? - Yahoo Finance

Alkane Resources (ASX:ALK): Is the Current Valuation Justified After Recent Share Price Surge?  Yahoo Finance

Alkane Resources (ASX:ALK): Is the Current Valuation Justified After Recent Share Price Surge? - Yahoo Finance

Click here to get full coverage on Young NSCLC Patients Have Advanced Disease, ALK Alterations - Medscape

Young NSCLC Patients Have Advanced Disease, ALK Alterations  Medscape

Young NSCLC Patients Have Advanced Disease, ALK Alterations - Medscape

Click here to get full coverage on BRIGHTSTAR Evaluates Local Consolidative Therapy Plus Brigatinib for ALK-Rearranged NSCLC - Cancer Nursing Today

BRIGHTSTAR Evaluates Local Consolidative Therapy Plus Brigatinib for ALK-Rearranged NSCLC  Cancer Nursing Today

BRIGHTSTAR Evaluates Local Consolidative Therapy Plus Brigatinib for ALK-Rearranged NSCLC - Cancer Nursing Today

Click here to get full coverage on Alaska Air Group (ALK): Assessing Valuation Following Rising Costs and Downward Earnings Revisions - Yahoo Finance

Alaska Air Group (ALK): Assessing Valuation Following Rising Costs and Downward Earnings Revisions  Yahoo Finance

Alaska Air Group (ALK): Assessing Valuation Following Rising Costs and Downward Earnings Revisions - Yahoo Finance

Click here to get full coverage on Burnley owners ALK Capital in talks over buying Espanyol stake - The New York Times

Burnley owners ALK Capital in talks over buying Espanyol stake  The New York Times

Burnley owners ALK Capital in talks over buying Espanyol stake - The New York Times

Click here to get full coverage on Alaska Air Group (ALK) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Alaska Air Group (ALK) Stock Sinks As Market Gains: Here's Why  Yahoo Finance

Alaska Air Group (ALK) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Click here to get full coverage on Alaska Air Group, Inc. (ALK) Reports Q2 2025 Results; Earnings Beat Expectations - Yahoo Finance

Alaska Air Group, Inc. (ALK) Reports Q2 2025 Results; Earnings Beat Expectations  Yahoo Finance

Alaska Air Group, Inc. (ALK) Reports Q2 2025 Results; Earnings Beat Expectations - Yahoo Finance

Click here to get full coverage on Alaska Air Group (ALK) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance

Alaska Air Group (ALK) Beats Stock Market Upswing: What Investors Need to Know  Yahoo Finance

Alaska Air Group (ALK) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance

Click here to get full coverage on Neoadjuvant Alectinib Effective, Tolerable in Late-Stage ALK-Positive NSCLC - CancerNetwork

Neoadjuvant Alectinib Effective, Tolerable in Late-Stage ALK-Positive NSCLC  CancerNetwork

Neoadjuvant Alectinib Effective, Tolerable in Late-Stage ALK-Positive NSCLC - CancerNetwork

Click here to get full coverage on Case Report: Treatment response of SQSTM1–ALK fusion lung adenocarcinoma to multiple ALK inhibitors - Frontiers

Case Report: Treatment response of SQSTM1–ALK fusion lung adenocarcinoma to multiple ALK inhibitors  Frontiers

Case Report: Treatment response of SQSTM1–ALK fusion lung adenocarcinoma to multiple ALK inhibitors - Frontiers

Click here to get full coverage on Lorlatinib as First Treatment for ALK+ Lung Cancer - ALK Positive Inc. - Oncodaily

Lorlatinib as First Treatment for ALK+ Lung Cancer - ALK Positive Inc.  Oncodaily

ALK

Price Chart

Key Statistics

Technicals

About ALK

Latest News

Does Alaska Air Group’s (ALK) Rapid Response to FAA Disruptions Reflect Long-Term Operational Resilience? - Yahoo Finance

ALK-Abelló delivers 18% global revenue growth, profit up 41% - The Pharma Letter

ALK-abello A/S Earnings Call Highlights Growth and Challenges - TipRanks

Advanced Charts

Top Gainers

Top Losers